658 related articles for article (PubMed ID: 8182812)
1. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.
Pittet D; Tarara D; Wenzel RP
JAMA; 1994 May; 271(20):1598-601. PubMed ID: 8182812
[TBL] [Abstract][Full Text] [Related]
2. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit.
Digiovine B; Chenoweth C; Watts C; Higgins M
Am J Respir Crit Care Med; 1999 Sep; 160(3):976-81. PubMed ID: 10471627
[TBL] [Abstract][Full Text] [Related]
3. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.
Classen DC; Pestotnik SL; Evans RS; Lloyd JF; Burke JP
JAMA; 1997 Jan 22-29; 277(4):301-6. PubMed ID: 9002492
[TBL] [Abstract][Full Text] [Related]
4. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study.
Wisplinghoff H; Cornely OA; Moser S; Bethe U; Stützer H; Salzberger B; Fätkenheuer G; Seifert H
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):905-11. PubMed ID: 14700405
[TBL] [Abstract][Full Text] [Related]
6. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
Orsi GB; Di Stefano L; Noah N
Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
[TBL] [Abstract][Full Text] [Related]
7. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs.
Kirkland KB; Briggs JP; Trivette SL; Wilkinson WE; Sexton DJ
Infect Control Hosp Epidemiol; 1999 Nov; 20(11):725-30. PubMed ID: 10580621
[TBL] [Abstract][Full Text] [Related]
8. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
[TBL] [Abstract][Full Text] [Related]
9. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay.
Rosenthal VD; Guzman S; Orellano PW
Am J Infect Control; 2003 Aug; 31(5):291-5. PubMed ID: 12888765
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial blood-stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality.
Liu JW; Su YK; Liu CF; Chen JB
J Hosp Infect; 2002 Mar; 50(3):224-7. PubMed ID: 11886200
[TBL] [Abstract][Full Text] [Related]
11. Cost of Critically Ill Surgical Patients in Thailand: A Prospective Analysis of a Multicenter THAI-SICU Study.
Chatmongkolchart S; Chittawatanarat K; Akaraborworn O; Kitsiripant C
J Med Assoc Thai; 2016 Sep; 99 Suppl 6():S31-S37. PubMed ID: 29906072
[TBL] [Abstract][Full Text] [Related]
12. Nosocomial bloodstream infections in HIV-infected patients: attributable mortality and extension of hospital stay.
Tumbarello M; Tacconelli E; Donati KG; Leone F; Morace G; Cauda R; Ortona L
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):490-7. PubMed ID: 9859963
[TBL] [Abstract][Full Text] [Related]
13. Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.
Primo MG; Guilarde AO; Martelli CM; Batista LJ; Turchi MD
Braz J Infect Dis; 2012; 16(6):503-9. PubMed ID: 23158266
[TBL] [Abstract][Full Text] [Related]
14. [Nosocomial bacteremia in the adult patient. Study of associated costs].
Morano Amado LE; Del Campo Pérez V; López Miragaya I; Martínez Vázquez MJ; Vázquez Alvarez O; Pedreira Andrade JD
Rev Clin Esp; 2002 Sep; 202(9):476-84. PubMed ID: 12236937
[TBL] [Abstract][Full Text] [Related]
15. Hospital-acquired candidemia. The attributable mortality and excess length of stay.
Wey SB; Mori M; Pfaller MA; Woolson RF; Wenzel RP
Arch Intern Med; 1988 Dec; 148(12):2642-5. PubMed ID: 3196127
[TBL] [Abstract][Full Text] [Related]
16. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study.
Soufir L; Timsit JF; Mahe C; Carlet J; Regnier B; Chevret S
Infect Control Hosp Epidemiol; 1999 Jun; 20(6):396-401. PubMed ID: 10395140
[TBL] [Abstract][Full Text] [Related]
17. Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients.
García-Garmendia JL; Ortiz-Leyba C; Garnacho-Montero J; Jiménez-Jiménez FJ; Monterrubio-Villar J; Gili-Miner M
Crit Care Med; 1999 Sep; 27(9):1794-9. PubMed ID: 10507600
[TBL] [Abstract][Full Text] [Related]
18. Impact of nosocomial infections on medical costs, hospital stay, and outcome in hospitalized patients.
Sheng WH; Chie WC; Chen YC; Hung CC; Wang JT; Chang SC
J Formos Med Assoc; 2005 May; 104(5):318-26. PubMed ID: 15959598
[TBL] [Abstract][Full Text] [Related]
19. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: A prospective, matched analysis.
Rosenthal VD; Guzman S; Migone O; Crnich CJ
Am J Infect Control; 2003 Dec; 31(8):475-80. PubMed ID: 14647110
[TBL] [Abstract][Full Text] [Related]
20. Healthcare-Associated Infections Due to Multidrug-Resistant Organisms: a Surveillance Study on Extra Hospital Stay and Direct Costs.
Giraldi G; Montesano M; Napoli C; Frati P; La Russa R; Santurro A; Scopetti M; Orsi GB
Curr Pharm Biotechnol; 2019; 20(8):643-652. PubMed ID: 30961489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
